Essential thrombocythemia, abbreviated ET, is a rare chronic blood cancer of the kind called a myeloproliferative neoplasm, studied within hematology. It is characterised by the overproduction of platelets, also called thrombocytes, by megakaryocytes in the bone marrow. It belongs to the group of blood cancers in which the bone marrow produces too many white cells, red cells or platelets. Although this is rare, essential thrombocythemia may develop over time into acute myeloid leukemia or into myelofibrosis.
Facts
Classification
Body SystemLymphatic or Immune System 1 ICD-10 Chapter Communicable or Non-communicable Sources
1. National Library of Medicine: MeSH Descriptor Data: Thrombocythemia, Essential
National Library of MedicineMeSH tree number C15.378.463.825Quote, MeSH tree number C15.378.463.825
A clinical syndrome characterized by repeated spontaneous hemorrhages and a remarkable increase in the number of circulating platelets.
2. Essential thrombocythemia (Wikipedia)
Lead section
rare chronic blood cancer (myeloproliferative neoplasm)
Lead: disease category
In hematology, essential thrombocythemia (ET) is a rare chronic blood cancer (myeloproliferative neoplasm) characterised by the overproduction of platelets (thrombocytes) by megakaryocytes in the bone marrow.
View the SourceReader Challenges (0)
No disputes yet. Spotted an error or a better source? Open the first one.
Sign in to dispute this or suggest a correction.